![](/img/cover-not-exists.png)
PCN174 ADVERSE EVENTS ASSOCIATED WITH IMMUNOTHERAPIES USED IN THE TREATMENT OF STAGE 3 AND 4 MELANOMA
Llewellyn, S., Åkesson, C., Kousoulakou, H., Larkin, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.296
Date:
May, 2019
File:
PDF, 381 KB
english, 2019